Consun Pharmaceutical Group Limited Stock
Stocks
1681
KYG2524A1031
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Hong Kong S.E.
04:08:13 2026-09-01 EDT
|
5-day change | 1st Jan Change | ||
| 13.52 HKD | -0.07% |
|
+0.97% | -13.55% |
| Market Cap | 9.72B 11.34B 1.45B 1.25B 1.17B 1.07B 2.01B 137B 2.02B 13.88B 5.4B 69.85B 5.43B 5.31B 232B | P/E 2026 * |
7.91x | P/E 2027 * | 7.18x |
|---|---|---|---|---|---|
| Enterprise Value | 9.72B 11.34B 1.45B 1.25B 1.17B 1.07B 2.01B 137B 2.02B 13.88B 5.4B 69.85B 5.43B 5.31B 232B | EV / Sales 2026 * |
2.5x | EV / Sales 2027 * | 2.24x |
| Free-Float |
54.2% | Yield 2026 * |
6.38% | Yield 2027 * | 7.02% |
| 1 day | -0.07% | ||
| 1 week | +0.97% | ||
| Current month | -0.07% | ||
| 1 month | -1.24% | ||
| 3 months | -4.65% | ||
| 6 months | -24.89% | ||
| Current year | -13.55% |
| 1 week | 13.37 | 15.27 | |
| 1 month | 13.11 | 15.27 | |
| Current year | 12.31 | 19.49 | |
| 1 year | 12.31 | 19.49 | |
| 3 years | 4.31 | 19.49 | |
| 5 years | 2.92 | 19.49 | |
| 10 years | 2.61 | 19.49 |
| Manager | Title | Age | Since |
|---|---|---|---|
Meng An
CEO | Chief Executive Officer | 54 | 2024-01-16 |
Yu Jun Chen
DFI | Director of Finance/CFO | 46 | 2025-02-23 |
Hai En Gao
SEC | Corporate Secretary | 58 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Quan Zhu
BRD | Director/Board Member | 86 | 2012-12-23 |
Zhong Shi Feng
BRD | Director/Board Member | 67 | 2013-12-01 |
Meng An
CHM | Chairman | 54 | 2021-07-08 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.07% | +0.97% | -9.20% | +161.00% | 1.45B | ||
| -2.81% | +0.99% | +20.98% | +73.53% | 50.05B | ||
| -0.52% | +2.03% | +55.47% | +123.10% | 40.29B | ||
| +0.56% | +5.80% | +19.04% | +86.59% | 12.17B | ||
| +0.98% | -1.04% | -10.47% | +13.15% | 11.96B | ||
| +0.57% | +2.72% | +31.59% | +153.11% | 9.25B | ||
| -0.15% | -1.65% | +27.65% | +48.56% | 7.62B | ||
| -0.39% | +3.33% | +28.41% | +222.15% | 7.36B | ||
| -0.26% | +1.00% | +45.83% | -10.29% | 7.21B | ||
| -0.13% | +0.79% | -36.70% | +15.26% | 5.26B | ||
| Average | -0.20% | +1.15% | +17.26% | +88.62% | 15.26B | |
| Weighted average by Cap. | -0.92% | +1.80% | +27.70% | +88.53% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.88B 4.53B 578M 498M 469M 427M 803M 54.82B 807M 5.54B 2.16B 27.88B 2.17B 2.12B 92.46B | 4.35B 5.08B 647M 558M 525M 478M 900M 61.43B 905M 6.21B 2.42B 31.25B 2.43B 2.38B 104B |
| Net income | 1.24B 1.44B 184M 159M 149M 136M 256M 17.45B 257M 1.76B 686M 8.88B 690M 675M 29.43B | 1.36B 1.59B 203M 175M 164M 150M 282M 19.24B 283M 1.94B 757M 9.79B 761M 744M 32.45B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-01 | HK$13.52 | -0.07% | 1,683,000 |
| 26-08-31 | HK$13.53 | -4.25% | 2,133,000 |
| 26-08-28 | HK$14.13 | +2.47% | 2,819,882 |
| 26-08-27 | HK$13.79 | -7.64% | 5,031,396 |
| 26-08-26 | HK$14.93 | +11.42% | 8,349,662 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Annual profits - Rate of surprise
- Stock Market
- Stocks
- 1681 Stock
Select your edition
All financial news and data tailored to specific country editions
















